The Department of Defense (DoD) is offering this grant to support innovative translational research specifically addressing critical problems and questions in ovarian cancer. This grant is for accelerating the movement of promising ideas toward clinical applications, facilitating early-stage translation from laboratory discoveries to the clinic, or conversely, from clinical observations back to the laboratory for further study. It aims to provide a catalyst to challenge or expand current thinking and approaches in ovarian cancer. Research ideas can be derived from various sources including laboratory findings, literature reviews, population-based studies, novel clinical trial results, or a clinician’s firsthand knowledge. While not required, preliminary data is allowed, and proposals should demonstrate strong scientific rationale.
Opportunity ID: 51374
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-10-OCRP-TPA |
Funding Opportunity Title: | DoD Ovarian Cancer Translational Pilot Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 12 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 27, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jun 10, 2010 |
Current Closing Date for Applications: | Jun 10, 2010 |
Archive Date: | Jul 10, 2010 |
Estimated Total Program Funding: | $4,100,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | NEW for FY10, the OCRP Translational Pilot Award mechanism supports innovative translational research addressing a critical problem or question in ovarian cancer that will accelerate the movement of promising ideas toward clinical applications. The proposed research should provide a catalyst to challenge or expand current thinking and/or approaches to ovarian cancer. It must involve early-stage translation of an idea from the laboratory to the clinic, or from the clinic back to the laboratory. Observations that generate a translational pilot research idea may be derived from a laboratory discovery, literature review, population-based studies, novel findings from a clinical trial, or a clinicians firsthand knowledge of patients and anecdotal data. Preliminary data are not required, but are allowed. The strength of the proposal should be based on sound scientific rationale and logical reasoning. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 51374 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 51374 Full Announcement-1 -> ocrp_fy10 translational pilot pa_final.pdf
Folder 51374 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Packages
Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00016079 | Jan 27, 2010 | Jun 10, 2010 | View |
Package 1
Mandatory forms
51374 RR_SF424_1_2-1.2.pdf
51374 PerformanceSite_1_4-1.4.pdf
51374 RR_KeyPersonExpanded_1_2-1.2.pdf